Hormone therapy: Difference between revisions

Jump to navigation Jump to search
 
Line 34: Line 34:
* Chemical castration of violent sex offenders
* Chemical castration of violent sex offenders


==Adverse effects of testosterone--
==Adverse effects of testosterone==
Testosterone may in case cardiovascular disease in older males<ref name="pmid20592293">{{cite journal| author=Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM | display-authors=etal| title=Adverse events associated with testosterone administration. | journal=N Engl J Med | year= 2010 | volume= 363 | issue= 2 | pages= 109-22 | pmid=20592293 | doi=10.1056/NEJMoa1000485 | pmc=3440621 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20592293  }}  [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=&cmd=prlinks&id=21173408 Review in: Ann Intern Med. 2010 Dec 21;153(12):JC6-7] </ref>.
Testosterone may in case cardiovascular disease in older males<ref name="pmid20592293">{{cite journal| author=Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM | display-authors=etal| title=Adverse events associated with testosterone administration. | journal=N Engl J Med | year= 2010 | volume= 363 | issue= 2 | pages= 109-22 | pmid=20592293 | doi=10.1056/NEJMoa1000485 | pmc=3440621 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20592293  }}  [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=&cmd=prlinks&id=21173408 Review in: Ann Intern Med. 2010 Dec 21;153(12):JC6-7] </ref>.
The [[Food and Drug Administration]] was warned of dangers from testosterone<ref>Food and Drug Administration. DA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use. 02/2018. Available at https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-cautions-about-using-testosterone-products-low-testosterone-due</ref><ref>Food and Drug Administration. FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use. 03/2015. Available at https://wayback.archive-it.org/7993/20161022203711/http://www.fda.gov/Drugs/DrugSafety/ucm436259.htm</ref>


<br>
<br>

Latest revision as of 22:07, 4 December 2022

WikiDoc Resources for Hormone therapy

Articles

Most recent articles on Hormone therapy

Most cited articles on Hormone therapy

Review articles on Hormone therapy

Articles on Hormone therapy in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hormone therapy

Images of Hormone therapy

Photos of Hormone therapy

Podcasts & MP3s on Hormone therapy

Videos on Hormone therapy

Evidence Based Medicine

Cochrane Collaboration on Hormone therapy

Bandolier on Hormone therapy

TRIP on Hormone therapy

Clinical Trials

Ongoing Trials on Hormone therapy at Clinical Trials.gov

Trial results on Hormone therapy

Clinical Trials on Hormone therapy at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hormone therapy

NICE Guidance on Hormone therapy

NHS PRODIGY Guidance

FDA on Hormone therapy

CDC on Hormone therapy

Books

Books on Hormone therapy

News

Hormone therapy in the news

Be alerted to news on Hormone therapy

News trends on Hormone therapy

Commentary

Blogs on Hormone therapy

Definitions

Definitions of Hormone therapy

Patient Resources / Community

Patient resources on Hormone therapy

Discussion groups on Hormone therapy

Patient Handouts on Hormone therapy

Directions to Hospitals Treating Hormone therapy

Risk calculators and risk factors for Hormone therapy

Healthcare Provider Resources

Symptoms of Hormone therapy

Causes & Risk Factors for Hormone therapy

Diagnostic studies for Hormone therapy

Treatment of Hormone therapy

Continuing Medical Education (CME)

CME Programs on Hormone therapy

International

Hormone therapy en Espanol

Hormone therapy en Francais

Business

Hormone therapy in the Marketplace

Patents on Hormone therapy

Experimental / Informatics

List of terms related to Hormone therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Hormone therapy, or hormonal therapy is the use of hormones in medical treatment. Treatment with hormone antagonists may also referred to as hormonal therapy. Wikipedia has the following articles regarding this topic:

Cancer

Aging

Depression

Testosterone therapy[1], especially among males with low testosterone levels. Testosterone may improve depressive symptoms in hypogonadal, older males[2].

Sex reassignment

Intersex conditions

Hormonal deficiency

Metabolism

Testosterone therapy may[3] or may not[4] improve the metabolism of glucose and lipids.

Psychological treatment

  • Chemical castration of violent sex offenders

Adverse effects of testosterone

Testosterone may in case cardiovascular disease in older males[5].

The Food and Drug Administration was warned of dangers from testosterone[6][7]




de:Hormontherapie nl:Hormoonbehandeling fi:Hormonihoito


Template:WikiDoc Sources

  1. Walther A, Breidenstein J, Miller R (2019). "Association of Testosterone Treatment With Alleviation of Depressive Symptoms in Men: A Systematic Review and Meta-analysis". JAMA Psychiatry. 76 (1): 31–40. doi:10.1001/jamapsychiatry.2018.2734. PMC 6583468 Check |pmc= value (help). PMID 30427999.
  2. Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA; et al. (2016). "Effects of Testosterone Treatment in Older Men". N Engl J Med. 374 (7): 611–24. doi:10.1056/NEJMoa1506119. PMC 5209754. PMID 26886521. Review in: Ann Intern Med. 2016 May 17;164(10):JC56
  3. Jones TH, Arver S, Behre HM, Buvat J, Meuleman E, Moncada I; et al. (2011). "Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study)". Diabetes Care. 34 (4): 828–37. doi:10.2337/dc10-1233. PMC 3064036. PMID 21386088.
  4. Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, Aleman A, Lock TM, Bosch JL; et al. (2008). "Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial". JAMA. 299 (1): 39–52. doi:10.1001/jama.2007.51. PMID 18167405. Review in: ACP J Club. 2008 May 20;148(3):4 Review in: Evid Based Med. 2008 Jun;13(3):71
  5. Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM; et al. (2010). "Adverse events associated with testosterone administration". N Engl J Med. 363 (2): 109–22. doi:10.1056/NEJMoa1000485. PMC 3440621. PMID 20592293. Review in: Ann Intern Med. 2010 Dec 21;153(12):JC6-7
  6. Food and Drug Administration. DA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use. 02/2018. Available at https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-cautions-about-using-testosterone-products-low-testosterone-due
  7. Food and Drug Administration. FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use. 03/2015. Available at https://wayback.archive-it.org/7993/20161022203711/http://www.fda.gov/Drugs/DrugSafety/ucm436259.htm